|
| My favourite pages |
| Support topics
Need help in something? Take a look at our support area for your answer. Find out more |
|
|
| My favourite pages |
| Support topics
Need help in something? Take a look at our support area for your answer. Find out more |
Session Timeout
You have been inactive for 0 mins.
Stay logged in or you will be logged off in 60 seconds.
This fund was launched in 2018 to replicate a successful strategy employed by T. Rowe Price in the US. The manager, Taymour Tamaddon, has managed the fund since launch and has a solid background in the US market as a healthcare sector specialist. He has carefully implemented this well-established process that draws on in-house research, taking advantage of the research analysts' top ideas. He has a bias to companies with double-digit earnings potential over 3 years and invests in firms with strong market positions, high reputations, good management and strong cash flow. The fund is very concentrated, only holding 60-75 stocks with the top 20 being half the fund.
Below is the online factsheet for your selected instrument. You can change time periods in certain areas of the factsheet and generate a version to PDF using the "Print" button.
You can also view an Analyst Report as a PDF using the link below and if you are a registered user a more detailed report is also available.
Analyst Report
